Latest ArticlesTopical dermatological preparations, particularly locally acting generic products, face challenges in bioequivalence(BE) assessment due to the inapplicability of pharmacokinetic(PK)-based endpoints and the high cost and complexity of clinical endpoint studies. This problem has prompted regulatory agencies to develop alternative in vitro and in vivo methods based on non-clinical endpoints for BE evaluation. Among these approaches, the characterization of physicochemical and structural properties(Q3) serves as an in vitro testing method that predicts and compares product quality and drug performance by assessing the physicochemical and structural attributes of formulations, thereby providing scientific supports for in vitro BE demonstration of topical preparations. This article systematically reviews the progress in Q3 characterization of topical dermatological preparations based on guidance documents issued by regulatory agencies and relevant literature worldwide.
The viscoelastic properties of pressure sensitive adhesives constitute a pivotal quality attribute when for mulating transdermal patches. And the viscoelasticity can generally be characterized by rheological measurement methods. This article reviews cutting-edge technologies such as rheological steady-state tests, dynamic tests, transient tests and the time-temperature superposition principle. On this basis, it further sorts out the viscoelasticity of pressure sensitive adhesives for pharmaceutical excipients and its correlations with adhesion properties, drug release kinetics and intermolecular forces. Finally, it summarizes the applications of rheological evaluation as a process analysis technique in the optimization of pressure sensitive adhesive formulations, production processes and the precise regulation of adhesive properties, so as to provide more scientific and reasonable theoretical supports and practical guidelines for the adhesive industry and further promote the development of transdermal drug delivery systems.
Antibody drugs have played a significant role in the clinical treatment of diseases such as tumors and autoimmune diseases, owing to their strong specificity and minimal adverse reactions. With the rapid development of antibody drug research and production, the need to accelerate structural characterization to shorten the research and production cycle, and to ensure the safety and efficacy of drugs, is becoming increasingly significant. High throughput and automation are currently the development trends for rapid structural characterization. Mass spectrometry technology has shown significant advantages in monitoring the complex mass properties of biopharmaceuticals, especially high-resolution mass spectrometry playing an increasingly important role in the structural characterization of macromolecular drugs. This study summarizes multiple new strategies for analyzing the structure of antibody drugs using mass spectrometry, aiming to reduce sample pretreatment processes, accelerate antibody characterization efficiency, and expedite upstream drug development, offering valuable references for rapid and comprehensive quality monitoring of antibody drugs.
Traditional therapies for cutaneous melanoma show poor specificity and yield unsatisfactory treatment outcomes. The emerging field of immunotherapy has introduced novel strategies for combating cutaneous melanoma. However, its clinical application is limited by low delivery efficiency. Responsive microneedle-based immunotherapy drug delivery systems effectively compensate for this deficiency. They not only show ideal delivery efficiency but also enable targeted drug delivery, thereby exerting a significant inhibitory effect on melanoma growth. This article reviews the application of responsive microneedle delivery systems in the immunotherapy of cutaneous melanoma, providing a reference for future immunotherapy research and advancing the development of clinical treatments.
Resmetirom(1) is the first FDA-approved drug for the treatment of non-alcoholic steatohepatitis(NASH) in 2024. It is primarily used in clinical settings to address stage F2 and F3 liver fibrosis associated with non-alcoholic steatohepatitis. The drug exhibits favorable safety and efficacy, thereby generating substantial market demand. Consequently, investigating a synthesis method suitable for industrial-scale production of 1 holds immense significance. 6-(4-Amino-2,6-dichlorophenoxy)-4- isopropylpyridazin-3(2H)-one(2) is a key intermediate for the synthesis of 1 . This review summarizes the strategies and specific feasible synthetic routes of key intermediate 2 and the target product 1 , providing a reference for the research of its synthesis process.
The ionizable cationic lipid, heptadecan-9-yl 8-[(2-hydroxyethyl) [8-(nonyloxy)-8-oxooctyl]amino]-octanoate(1), is an important component in delivery systems of nucleic acid drugs. In this paper, an improved synthetic process of 1 was developed. Nonyl 8-bromooctanoate(4) was synthesized by esterification from the commercially available material 1-nonanol(2) with 8-bromooctanoic acid(3). Heptadecan-9-ol(7) was synthesized by Grignard reaction from nonanal(5) with n-octylmagnesium bromide(6). 8-Aminooctanoic acid(11), as another starting material, was reacted with di-tert-butyl dicarbonate[(Boc)2O] to obtain 8-[(tert-butoxycarbonyl) amino]octanoic acid(12). 8-[(tert-Butoxycarbonyl) amino]octanoate-1-octylnonyl ester(13), which was synthesized by esterification from 12 with 7 , reacted with trifluoroacetic acid to obtain 8-aminooctanoate-1-octylnonyl ester(14). Then, 8-[[8-(nonyloxy)-8-oxooctyl]amino]-octanoate-1-octylnonyl ester(15) was synthesized via the nucleophilic substitution reaction with 14 and 4 . Finally, the target 1 was obtained from 15 and 2-bromoethanol by nucleophilic substitution reaction with the purity of 98.6%. Compared with the reported routes, the overall yield increased from 7.6% to 32.7%(based on 2), and the yield of the two-step reaction from 14 to 1 raised from 20.1% to 49.2%.
Twin screw granulation(TSG) is a commonly used process for the continuous manufacturing of oral solid dosage forms. However, due to the fact that the granules obtained under high shear forces during the TSG process are denser and high molecular weight hydrophilic matrix materials are difficult to co-extrude, the application of TSG in hydrophilic gel matrix tablets, especially gastric floating hydrophilic gel matrices, is limited. At present, most matrix tablets are still prepared by high-shear granulation followed by the external addition of HPMC and subsequent tableting. In this study, by optimizing the screw design and process parameters, the feasibility of achieving “one-step” TSG granulation of floating extended-release matrix granules based on HPMC was investigated. The flowability, density, particle size of the granules, and the buoyancy, gel strength, and dissolution profile of the tablets were used as response parameters to optimize process parameters such as the number of kneading blocks, the staggering angle of kneading elements, the intervals between mixing zones, barrel temperature, liquid-to-solid ratio, mass feeding rate, and screw speed. The results showed that the screw design and process parameters had a potential impact on the properties of the prepared granules and hydrophilic gel matrix tablets, and the continuous production of gastric floating extended-release matrices could be achieved by optimizing relevant parameters.
In order to prepare a synthetic pulmonary surfactant suspension that meets quality standards, this study employed Design of Experiment(DOE) to optimize process parameters. The particle size and surface activity, which are key quality attributes of the product, were used as the main evaluation indicators. The response surface methodology was adopted to optimize process parameters such as dispersion temperature, stirring speed, and dispersion time. The optimized process parameters were determined as follows: dissolution temperature of 40–42℃, stirring speed of 500–600 r/min, and stirring time of 3–5 min. The samples prepared with the optimized process all met the quality requirements. It indicated that the optimized process were stable and reliable, providing a technical support for the production of synthetic pulmonary surfactant preparations.
The chemical composition and fragmentation pattern in mass spectra of Huazhi Rougan granules was analyzed, and the quality marker(Q-Marker) for their hepatoprotective effect was explored. An HPLC-DAD method was adopted to establish a fingerprint and evaluate similarity. A UPLC-Q-Exactive MS method was adopted for component identification, and the Q-marker of Huazhi Rougan granules was predicted based on the “Five Principles” of Q-marker. The results showed that there were 23 common peaks in the established HPLC fingerprint, and 6 components were identified, namely p-hydroxycinnamic acid, naringin, hesperidin, chlorogenic acid, emodin, and chrysophanol. The similarity of 12 batches was no less than 0.97. A total of 73 compounds were identified by UPLC-Q-Exactive MS, including 4 flavonoids, 15 flavonoid glycosides, 14 organic acids, 9 anthraquinones, 15 glycosides, 6 triterpenoid saponins, 4 terpenoids, 3 coumarins,2 phenylethanols, 1 lactone. Based on the “Five Principles” of Q-Markers, it was predicted that 9 compounds, namely p-hydroxycinnamic acid, chlorogenic acid, naringin, hesperidin, buddleoside, aurantio-obtusin, saikosaponin A, emodin and chrysophanol can be used as Q-Markers for Huazhi Rougan granules, which provides a theoretical basis for the quality improvement in the industrial production of Huazhi Rougan granules.
This study optimized the preparation process of Ginkgo biloba leaf extract using a deterministic screening experimental design, investigating the impacts of multiple batches of Ginkgo biloba leaf raw materials and 12 process parameters. The process evaluation indexes were determined as dry matter content, total flavonoid glycoside content, total terpenoid lactone content, total organic acid content. Critical material attributes(CMAs) were identified as the contents of isorhamnetin, ginkgolide C, and protocatechuic acid in raw materials. Critical process parameters(CPPs) were identified as the volume fraction of ethanol for extraction, the volume of water used in the water sedimentation, volume fraction of ethanol for washing, washing volume, and elution volume. The mathematical models were established between CMAs, CPPs, and process evaluation indexes. The design space was determined based on the risk level, and a robust operating space was recommended. Operating within the operating space ensures the quality of the Ginkgo biloba leaf extract. The established parameter optimization method is applicable when there are variations in the quality of raw material batches, and it can be used to prepare extracts with more consistent quality, showing promising potential for widespread application.